vs
Evolent Health, Inc.（EVH）与富兰克林柯维（FC）财务数据对比。点击上方公司名可切换其他公司
Evolent Health, Inc.的季度营收约是富兰克林柯维的7.3倍（$468.7M vs $64.0M）。富兰克林柯维净利率更高（-5.1% vs -91.6%，领先86.4%）。富兰克林柯维同比增速更快（-7.3% vs -27.5%）。过去两年富兰克林柯维的营收复合增速更高（2.2% vs -14.4%）
马奎尔健康是一家美国营利性医疗管理企业，目前为森特里奇旗下子公司，核心服务对象为特殊群体，业务聚焦医疗领域多个细分赛道。客户群体涵盖健康保险计划、其他管理式医疗机构、企业、工会、各类军事与政府机构以及第三方管理机构，2021年位列财富美国500强第390名。
富兰克林柯维总部位于美国犹他州盐湖城，是一家专业培训指导企业，面向各类组织与个人提供领导力提升、个人效能成长与业务执行领域的培训及评估服务。公司由富兰克林奎斯特与柯维领导力中心于1997年合并成立，最为人熟知的产品包括富兰克林柯维规划系统等。
EVH vs FC — 直观对比
营收规模更大
EVH
是对方的7.3倍
$64.0M
营收增速更快
FC
高出20.2%
-27.5%
净利率更高
FC
高出86.4%
-91.6%
两年增速更快
FC
近两年复合增速
-14.4%
损益表 — Q4 2025 vs Q1 2026
| 指标 | | |
|---|---|---|
| 营收 | $468.7M | $64.0M |
| 净利润 | $-429.1M | $-3.3M |
| 毛利率 | 20.7% | 75.5% |
| 营业利润率 | -87.1% | -5.7% |
| 净利率 | -91.6% | -5.1% |
| 营收同比 | -27.5% | -7.3% |
| 净利润同比 | -1782.0% | -378.5% |
| 每股收益（稀释后） | $-3.76 | $-0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EVHFC
| Q4 25 | $468.7M | $64.0M | ||
| Q3 25 | $479.5M | $71.2M | ||
| Q2 25 | $444.3M | $67.1M | ||
| Q1 25 | $483.6M | $59.6M | ||
| Q4 24 | $646.5M | $69.1M | ||
| Q3 24 | $621.4M | $84.1M | ||
| Q2 24 | $647.1M | $73.4M | ||
| Q1 24 | $639.7M | $61.3M |
净利润EVHFC
| Q4 25 | $-429.1M | $-3.3M | ||
| Q3 25 | $-20.9M | $4.4M | ||
| Q2 25 | $-19.9M | $-1.4M | ||
| Q1 25 | $-64.6M | $-1.1M | ||
| Q4 24 | $-22.8M | $1.2M | ||
| Q3 24 | $-23.1M | $12.0M | ||
| Q2 24 | $1.6M | $5.7M | ||
| Q1 24 | $-17.3M | $874.0K |
毛利率EVHFC
| Q4 25 | 20.7% | 75.5% | ||
| Q3 25 | 20.8% | 75.5% | ||
| Q2 25 | 22.6% | 76.5% | ||
| Q1 25 | 21.2% | 76.7% | ||
| Q4 24 | 11.7% | 76.3% | ||
| Q3 24 | 13.0% | 78.1% | ||
| Q2 24 | 16.5% | 76.6% | ||
| Q1 24 | 16.3% | 76.4% |
营业利润率EVHFC
| Q4 25 | -87.1% | -5.7% | ||
| Q3 25 | 0.2% | 11.1% | ||
| Q2 25 | -0.3% | -3.3% | ||
| Q1 25 | -0.3% | -2.4% | ||
| Q4 24 | -2.9% | 2.1% | ||
| Q3 24 | -2.6% | 21.3% | ||
| Q2 24 | 1.2% | 11.4% | ||
| Q1 24 | -2.1% | 2.4% |
净利率EVHFC
| Q4 25 | -91.6% | -5.1% | ||
| Q3 25 | -4.4% | 6.1% | ||
| Q2 25 | -4.5% | -2.1% | ||
| Q1 25 | -13.4% | -1.8% | ||
| Q4 24 | -3.5% | 1.7% | ||
| Q3 24 | -3.7% | 14.2% | ||
| Q2 24 | 0.2% | 7.8% | ||
| Q1 24 | -2.7% | 1.4% |
每股收益（稀释后）EVHFC
| Q4 25 | $-3.76 | $-0.27 | ||
| Q3 25 | $-0.24 | $0.34 | ||
| Q2 25 | $-0.44 | $-0.11 | ||
| Q1 25 | $-0.63 | $-0.08 | ||
| Q4 24 | $-0.26 | $0.09 | ||
| Q3 24 | $-0.27 | $0.89 | ||
| Q2 24 | $-0.06 | $0.43 | ||
| Q1 24 | $-0.22 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $151.9M | $17.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $415.2M | $54.0M |
| 总资产 | $1.9B | $221.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资EVHFC
| Q4 25 | $151.9M | $17.5M | ||
| Q3 25 | $116.7M | $31.7M | ||
| Q2 25 | $151.0M | $33.7M | ||
| Q1 25 | $246.5M | $40.4M | ||
| Q4 24 | $104.2M | $53.3M | ||
| Q3 24 | $96.6M | $48.7M | ||
| Q2 24 | $101.3M | $36.6M | ||
| Q1 24 | $165.1M | $40.9M |
股东权益EVHFC
| Q4 25 | $415.2M | $54.0M | ||
| Q3 25 | $842.2M | $66.9M | ||
| Q2 25 | $896.0M | $65.6M | ||
| Q1 25 | $935.5M | $72.5M | ||
| Q4 24 | $1.0B | $80.6M | ||
| Q3 24 | $1.0B | $83.1M | ||
| Q2 24 | $1.1B | $72.2M | ||
| Q1 24 | $1.0B | $70.8M |
总资产EVHFC
| Q4 25 | $1.9B | $221.3M | ||
| Q3 25 | $2.5B | $242.9M | ||
| Q2 25 | $2.5B | $218.3M | ||
| Q1 25 | $2.7B | $221.3M | ||
| Q4 24 | $2.5B | $239.9M | ||
| Q3 24 | $2.5B | $261.5M | ||
| Q2 24 | $2.5B | $221.0M | ||
| Q1 24 | $2.6B | $221.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $48.8M | $98.0K |
| 自由现金流经营现金流 - 资本支出 | — | $-1.6M |
| 自由现金流率自由现金流/营收 | — | -2.5% |
| 资本支出强度资本支出/营收 | — | 2.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $5.9M |
8季度趋势，按日历期对齐
经营现金流EVHFC
| Q4 25 | $48.8M | $98.0K | ||
| Q3 25 | $15.8M | $9.9M | ||
| Q2 25 | $-30.3M | $6.3M | ||
| Q1 25 | $4.6M | $-1.4M | ||
| Q4 24 | $-26.2M | $14.1M | ||
| Q3 24 | $18.7M | $21.9M | ||
| Q2 24 | $21.4M | $8.2M | ||
| Q1 24 | $4.9M | $12.8M |
自由现金流EVHFC
| Q4 25 | — | $-1.6M | ||
| Q3 25 | — | $5.7M | ||
| Q2 25 | — | $4.5M | ||
| Q1 25 | — | $-2.6M | ||
| Q4 24 | — | $13.1M | ||
| Q3 24 | — | $20.8M | ||
| Q2 24 | — | $7.3M | ||
| Q1 24 | — | $12.1M |
自由现金流率EVHFC
| Q4 25 | — | -2.5% | ||
| Q3 25 | — | 8.0% | ||
| Q2 25 | — | 6.7% | ||
| Q1 25 | — | -4.4% | ||
| Q4 24 | — | 19.0% | ||
| Q3 24 | — | 24.7% | ||
| Q2 24 | — | 9.9% | ||
| Q1 24 | — | 19.8% |
资本支出强度EVHFC
| Q4 25 | — | 2.7% | ||
| Q3 25 | — | 5.9% | ||
| Q2 25 | — | 2.7% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 1.4% | ||
| Q3 24 | — | 1.3% | ||
| Q2 24 | — | 1.2% | ||
| Q1 24 | — | 1.0% |
现金转化率EVHFC
| Q4 25 | — | — | ||
| Q3 25 | — | 2.27× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 11.98× | ||
| Q3 24 | — | 1.83× | ||
| Q2 24 | 13.42× | 1.43× | ||
| Q1 24 | — | 14.62× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EVH
| Commercial And Other Customers | $147.9M | 32% |
| Medicare Customers | $111.2M | 24% |
| Specialty Technology And Services Suite | $95.7M | 20% |
| Administrative Service | $55.8M | 12% |
| Cases | $47.7M | 10% |
| Related Party | $4.5M | 1% |
FC
暂无分部数据
